A phase I study of 5-fluorouracil, leucovorin and levamisole

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 4, 1997, Pages 300-306

  Cleary, James F ^a   Arzoomanian, Rhoda ^a   Alberti, Donna ^a   Feierabend, Chris ^a   Storer, Barry ^a   Witt, Pauline ^b   Carbone, Paul ^a   Wilding, George ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

5 Fluorouracil; Leucovorin; Levamisole; Phase I; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; DIARRHEA; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DIARRHEA; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LEVAMISOLE; MALE; MIDDLE AGED; STOMATITIS;

EID: 0031035156     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050576     Document Type: Article

References (30)

1. Arbuck SG, Douglass HO, Trave F (1987) A phase II trial of 5-fluorouracil and high dose intravenous leucovorin in gastriccarcinoma. J Clin Oncol 5:1150
2. Bartl R, Frisch B, Diem H, Mundel M, Nagel D, Lamerz R, Fateh-Moghadam A (1991) Histologic, biochemical and chemical parameters for monitoring multiple myeloma. Cancer 68:2241
3. Belle HV (1976) Alkaline phosphatase 1. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 22:972
4. Bertrand M, Doroshow JH, Multhauf P, Blayney DW, Carr BI, Cecchi G, Goldberg D, Leong L, Margolin K, Metter G, Staples R (1986) High-dose continuous infusion folic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study. J Clin Oncol 4:1058
5. Bruckner HW, Motwani BT (1991) Chemotherapy of advanced cancer of the colon and rectum. Semin Oncol 18:443
6. Cassidy J (1994) Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens. Br J Cancer 69:986
7. Chlebowski RT, Lillington L, Nystrom JS, Sayre J (1994) Late mortality and levamisole adjuvant therapy in colorectal cancer. Br J Cancer 69:1094
8. Cooper EH, Forbes MA, Humbling MH (1984) Serum beta2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol 37:1140
9. Erlichman CE, Fine S, Wong A, Elhakim T (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal cancer. J Clin Oncol 6:469
10. Faanes RB, Dillon P, Yong SC (1977) Levamisole augments the cytotoxic T-cell response depending on the dose of drugs administered. Clin Exp Immunol 27:502
11. Grem JL, Hoth DF, Hamilton JM, King SA, Leylend-Jones B (1987) Overview of the current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep 71:1249
12. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Neiderwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin; release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310
13. Krown S, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D (1991) Relationship and prognostic value of endogenous interferon-alpha, beta2 microglobulin and neopterin serum levels in patients with Kaposi Sarcoma and AIDS. J Acquir Immune Defic Syndr 4:871
14. Laurie JA, Moertel CG, Fleming TR (1989) Surgical adjuvant therapy of large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7:1447
15. Machover D, Goldschmidt E, Chollet P (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4:685
16. Madajewica S, Petrelli N, Rustum YM et al. (1984) Phase 1/11 trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 44:4667
17. Mathanson SD, Zamfirescu PL, Potaro JK, Kernion JB de, Fahey JL (1978) Acute effects on orally administered levamisole on random monocyte motility and chemotaxis in man. J Natl Cancer Inst 61:301
18. Moertel CG (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352
19. Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330:1136
20. Myers CE (1981) The pharmacology of the fluoropyrimidines. Pharmacol Rev 33: 1
21. NCI (1990) Adjuvant therapy for patients with colon and rectum cancer. NCI Consensus Statements 8: 1
22. Pike MC, Synderman R (1976) Augmentation of human monocyte chemotactic response by levamisole. Nature 261:133
23. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK, Wiesenfeld M (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7:1407
24. Ramot B, Binbiaminov M, Shoham C, Rosenthal E (1976) Effect of levamiosle on E rosette forming cells in vitro and in vivo in Hodgkin's disease. N Engl J Med 294:809
25. Renoux G (1980) The general pharmacology of levamisole. Drugs 19:89
26. Schiller JH, Witt PT, Storer BE, Alberti D, Tombes MB, Arzoomanian R, Brown RR, Proctor RA, Voss SD, Spriggs DR, Trump DL, Borden EC (1992) Clinical and biological effects of combination gamma Interferon and tumor necrosis factor. Cancer 69:562
27. Spreafico F (1980) Use of levamisole in cancer patients. Drugs 19:105
28. Takimoto CH (1995) Enigma of fluorouracil and levamisole. J Natl Cancer Inst 87:471
29. Witt PL, Storer BE, Bryan GT, Brown RR, Flashner M, Larocca AT, Colby CB, Borden EC (1993) Pharmacodynamics of biological response in vivo after single and mutiple doses of interferon-beta. J Immunother 13:191
30. Yin MB, Zakrzewski SF, Hakala MT (1983) Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. Mol Pharmacol 23:190